JUSRX
Price
$27.94
Change
+$0.20 (+0.72%)
Updated
Jul 31 closing price
Net Assets
31.72B
VSTSX
Price
$353.00
Change
+$2.01 (+0.57%)
Updated
Jul 31 closing price
Net Assets
2.3T
Interact to see
Advertisement

JUSRX vs VSTSX

JUSRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
JUSRX vs. VSTSX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUSRX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. JUSRX (31.7B). VSTSX pays higher dividends than JUSRX: VSTSX (1.08) vs JUSRX (0.50). JUSRX was incepted earlier than VSTSX: JUSRX (20 years) vs VSTSX (10 years). JUSRX (0.56) is less costly to investors than VSTSX (0.01). JUSRX is a more actively managed with annual turnover of: 39.00 vs. VSTSX (3.00). JUSRX has a lower initial minimum investment than VSTSX: JUSRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 18.52 vs. JUSRX (4.01). VSTSX return over 5 years is better than : 63.24 vs. JUSRX (28.70).
JUSRXVSTSXJUSRX / VSTSX
Total Expense Ratio0.540.015,400%
Annual Report Gross Expense Ratio0.560.015,600%
Fund Existence20 years10 years-
Gain YTD3.8009.88238%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets31.7B2.3T1%
Annual Yield % from dividends0.501.0846%
Returns for 1 year4.0118.5222%
Returns for 3 years38.6862.2462%
Returns for 5 years28.7063.2445%
Returns for 10 years110.57235.9747%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUSX18.240.13
+0.72%
Lazard US Equity Focus Instl
TAVFX84.490.15
+0.18%
Third Avenue Value Instl
FFNAX14.860.02
+0.13%
Fidelity Advisor Asset Manager 40% A
ZGFIX19.510.01
+0.05%
American Beacon Ninety One Gbl Frnchs R5
MRSRX28.14-0.17
-0.60%
MFS Research International R2